| abstract |
The invention provides a crystalline sulfate of 3-endo- (8- {2- [cyclohexylmethyl - ((S) -2,3-dihydroxypropionyl) amino] ethyl} -8-aza-bicyclo [3.2.1] oct -3-yl) benzamide or a solvate thereof. The invention also provides pharmaceutical compositions comprising such crystalline salts, methods of using such crystalline salts to treat diseases related to the activity of the m-opioid receptors, and processes useful for preparing such crystalline salts. |